These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17288745)

  • 1. Plasma homocysteine levels in patients treated with levodopa: motor and cognitive associations.
    Ozer F; Meral H; Hanoglu L; Aydemir T; Yilsen M; Cetin S; Ozturk O; Seval H; Koldas M
    Neurol Res; 2006 Dec; 28(8):853-8. PubMed ID: 17288745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine in restless legs syndrome.
    Bachmann CG; Guth N; Helmschmied K; Armstrong VW; Paulus W; Happe S
    Sleep Med; 2008 May; 9(4):388-92. PubMed ID: 17900981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate and vitamin B12 levels in levodopa-treated Parkinson's disease patients: their relationship to clinical manifestations, mood and cognition.
    Triantafyllou NI; Nikolaou C; Boufidou F; Angelopoulos E; Rentzos M; Kararizou E; Evangelopoulos ME; Vassilopoulos D
    Parkinsonism Relat Disord; 2008; 14(4):321-5. PubMed ID: 18055246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
    Xie Y; Feng H; Peng S; Xiao J; Zhang J
    Neurosci Lett; 2017 Jan; 636():190-195. PubMed ID: 27840145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced plasma homocysteine levels in levodopa/entacapone treated Parkinson patients.
    Valkovic P; Benetin J; Blazícek P; Valkovicová L; Gmitterová K; Kukumberg P
    Parkinsonism Relat Disord; 2005 Jun; 11(4):253-6. PubMed ID: 15878587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Homocysteine and cognitive impairment in Parkinson's disease].
    Martín-Fernández JJ; Carles-Díes R; Cañizares F; Parra S; Avilés F; Villegas I; Morsi-Hassan O; Fernández-Barreiro A; Herrero MT
    Rev Neurol; 2010 Feb 1-15; 50(3):145-51. PubMed ID: 20146187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease.
    Rogers JD; Sanchez-Saffon A; Frol AB; Diaz-Arrastia R
    Arch Neurol; 2003 Jan; 60(1):59-64. PubMed ID: 12533089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.
    Camicioli RM; Bouchard TP; Somerville MJ
    Mov Disord; 2009 Jan; 24(2):176-82. PubMed ID: 18951534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration.
    Lamberti P; Zoccolella S; Armenise E; Lamberti SV; Fraddosio A; de Mari M; Iliceto G; Livrea P
    Eur J Neurol; 2005 May; 12(5):365-8. PubMed ID: 15804266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson's disease patients: A randomized controlled study.
    Anamnart C; Kitjarak R
    J Clin Neurosci; 2021 Jun; 88():226-231. PubMed ID: 33992189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients.
    Lamberti P; Zoccolella S; Iliceto G; Armenise E; Fraddosio A; de Mari M; Livrea P
    Mov Disord; 2005 Jan; 20(1):69-72. PubMed ID: 15390046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patients.
    Caccamo D; Gorgone G; Currò M; Parisi G; Di Iorio W; Menichetti C; Belcastro V; Parnetti L; Rossi A; Pisani F; Ientile R; Calabresi P
    Neuromolecular Med; 2007; 9(3):249-54. PubMed ID: 17914182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease.
    O'Suilleabhain PE; Bottiglieri T; Dewey RB; Sharma S; Diaz-Arrastia R
    Mov Disord; 2004 Dec; 19(12):1403-8. PubMed ID: 15390053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia.
    Zoccolella S; dell'Aquila C; Abruzzese G; Antonini A; Bonuccelli U; Canesi M; Cristina S; Marchese R; Pacchetti C; Zagaglia R; Logroscino G; Defazio G; Lamberti P; Livrea P
    Mov Disord; 2009 May; 24(7):1028-33. PubMed ID: 19353704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.
    Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU
    West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with levodopa can affect latent vitamin B 12 and folic acid deficiency. Patients with Parkinson disease runt the risk of elevated homocysteine levels].
    Lökk J
    Lakartidningen; 2003 Aug; 100(35):2674-7. PubMed ID: 14531126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperhomocysteinemia and schizophrenia: case control study].
    Mabrouk H; Douki W; Mechri A; Younes MK; Omezzine A; Bouslama A; Gaha L; Najjar MF
    Encephale; 2011 Sep; 37(4):308-13. PubMed ID: 21981892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum homocysteine and physical exercise in patients with Parkinson's disease.
    Nascimento CM; Stella F; Garlipp CR; Santos RF; Gobbi S; Gobbi LT
    Psychogeriatrics; 2011 Jun; 11(2):105-12. PubMed ID: 21707858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications.
    Zoccolella S; Lamberti P; Armenise E; de Mari M; Lamberti SV; Mastronardi R; Fraddosio A; Iliceto G; Livrea P
    Parkinsonism Relat Disord; 2005 Mar; 11(2):131-3. PubMed ID: 15734674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The concentrations of homocysteine, folic acid and vitamin B12 in alcohol dependent male patients].
    Kopczyńska E; Ziółkowski M; Jendryczka-Maćkiewicz E; Odrowaz-Sypniewska G; Opozda K; Tyrakowski T
    Psychiatr Pol; 2004; 38(5):947-56. PubMed ID: 15523939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.